BioCryst Pharmaceuticals
BCRX
BCRX
177 hedge funds and large institutions have $898M invested in BioCryst Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 15 closing their positions.
Holders
177
Holders Change
+23
Holders Change %
+14.94%
% of All Funds
3.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
38
Increased
57
Reduced
57
Closed
15
Calls
$10.5M
Puts
$12.4M
Net Calls
-$1.99M
Net Calls Change
-$1.75M
Top Buyers
Top Sellers
1 |
1
State Street
Boston,
Massachusetts
|
$82.4M |
2 |
2
Millennium Management
New York
|
$2.14M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$48.4M |
4 |
4
Goldman Sachs
New York
|
$2.26M |
5 |
GTC
5
Ghost Tree Capital
New York
|
$6.71M |